Cargando…

Association of Body Fat Percentage with Time in Range Generated by Continuous Glucose Monitoring during Continuous Subcutaneous Insulin Infusion Therapy in Type 2 Diabetes

BACKGROUND: Obesity is a crucial risk factor associated with type 2 diabetes mellitus (T2DM). Excessive accumulation of body fat may affect the glycemia control in T2DM. This study investigated the relationship between body fat percentage and time in range (TIR) assessed by continuous glucose monito...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ruan, Yuting, Zhong, Jiana, Chen, Rongping, Zhang, Zhen, Liu, Dixing, Sun, Jia, Chen, Hong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8177984/ https://www.ncbi.nlm.nih.gov/pubmed/34136580 http://dx.doi.org/10.1155/2021/5551216

Ejemplares similares

Continuous subcutaneous insulin infusion and flash glucose monitoring in diabetic hemiballism-hemichorea
por: Qiang, Wei, et al.
Publicado: (2020)

Continuous subcutaneous insulin infusion: practical issues
por: Saboo, Banshi D., et al.
Publicado: (2012)

Faster Insulin Aspart for Continuous Subcutaneous Insulin Infusion: Is It Worth It?
por: Rosinha, Patrícia, et al.
Publicado: (2022)

A Continuous Subcutaneous Insulin Infusion Needle Break
por: George, Minu M., et al.
Publicado: (2015)

The association between fat-to-muscle ratio and metabolic disorders in type 2 diabetes
por: Liu, Dixing, et al.
Publicado: (2021)

Psychopathology and Continuous Subcutaneous Insulin Infusion in Type 1 Diabetes
por: Rotella, Francesco, et al.
Publicado: (2013)

Long-Term Effects of Initiating Continuous Subcutaneous Insulin Infusion (CSII) and Continuous Glucose Monitoring (CGM) in People with Type 1 Diabetes and Unsatisfactory Diabetes Control
por: Senn, Jon-Duri, et al.
Publicado: (2019)

Relationship Between Skeletal Muscle Mass to Visceral Fat Area Ratio and Cardiovascular Risk in Type 2 Diabetes
por: Liu, Dixing, et al.
Publicado: (2021)

Evaluation of the Accuracy of Current Tubeless Pumps for Continuous Subcutaneous Insulin Infusion
por: Ziegler, Ralph, et al.
Publicado: (2021)

Use of Continuous Glucose Monitoring in Subjects With Type 1 Diabetes on Multiple Daily Injections Versus Continuous Subcutaneous Insulin Infusion Therapy: A prospective 6-month study
por: Garg, Satish K., et al.
Publicado: (2011)

Accuracy of a subcutaneous continuous glucose monitor compared with an intravenous continuous glucose monitor in an intensive care unit
por: Takahashi, Y, et al.
Publicado: (2015)

Continuous subcutaneous insulin infusion is associated with a reduced rate of microvascular complications
por: Zabeen, Bedowra, et al.
Publicado: (2015)

Continuous subcutaneous insulin infusion in diabetes: patient populations, safety, efficacy, and pharmacoeconomics
por: Pozzilli, Paolo, et al.
Publicado: (2015)

Comparing the effectiveness of continuous subcutaneous insulin infusion with multiple daily insulin injection for patients with type 1 diabetes mellitus evaluated by retrospective continuous glucose monitoring: A real-world data analysis
por: Keyu, Guo, et al.
Publicado: (2022)

Glucose sensor-augmented continuous subcutaneous insulin infusion in patients with diabetic gastroparesis: An open-label pilot prospective study
por: Calles-Escandón, Jorge, et al.
Publicado: (2018)

Continuous Subcutaneous Insulin Infusion Characteristics in Type 1 Diabetes Children and Adolescents in Qatar
por: Petrovski, Goran, et al.
Publicado: (2018)

Subcutaneously implantable electromagnetic biosensor system for continuous glucose monitoring
por: Kim, Seongmun, et al.
Publicado: (2022)

Metformin add-on continuous subcutaneous insulin infusion on precise insulin doses in patients with type 2 diabetes
por: Li, Feng-fei, et al.
Publicado: (2018)

Continuous subcutaneous glucose monitoring: good enough to use in glucose regulation protocols?
por: Ligtenberg, Jack JM, et al.
Publicado: (2011)

Parents' experiences on the combined use of continuous subcutaneous insulin infusion and real‐time continuous glucose monitoring to manage Type 1 diabetes in their children: A systematic review and meta‐synthesis of qualitative studies
por: Luo, Xiuwen, et al.
Publicado: (2021)

A comparison of two insulin infusion protocols in the medical intensive care unit by continuous glucose monitoring
por: De Block, Christophe E. M., et al.
Publicado: (2016)

Combining continuous glucose monitoring and insulin pumps to automatically tune the basal insulin infusion in diabetes therapy: a review
por: Vettoretti, Martina, et al.
Publicado: (2019)

Outcomes for continuous subcutaneous insulin infusion users in young adults from lower socioeconomic backgrounds
por: McKee, Alexis M., et al.
Publicado: (2021)

Insulin Pump for Type 2 Diabetes: Use and misuse of continuous subcutaneous insulin infusion in type 2 diabetes
por: Reznik, Yves, et al.
Publicado: (2013)

Detailed Analysis of Insulin Absorption Variability and the Tissue Response to Continuous Subcutaneous Insulin Infusion Catheter Implantation in Swine
por: Hauzenberger, Jasmin R., et al.
Publicado: (2017)

A Review of Insulin-Dosing Formulas for Continuous Subcutaneous Insulin Infusion (CSII) for Adults with Type 1 Diabetes
por: King, Allen B., et al.
Publicado: (2016)

Continuous subcutaneous insulin infusion therapy is associated with reduced retinopathy progression compared with multiple daily injections of insulin
por: Reid, Laura J., et al.
Publicado: (2021)

Efficacy of Vildagliptin Added to Continuous Subcutaneous Insulin Infusion (CSII) in Hospitalized Patients with Type 2 Diabetes
por: Lyu, Fu-ping, et al.
Publicado: (2020)

Subcutaneous glucagon infusion and continuous glucose monitoring enable effective management of hypoglycemia in a patient with IGF-2-producing hemangiopericytoma
por: Buras, Eric D., et al.
Publicado: (2018)

The relationship between the frequency of self-monitoring of blood glucose and glycemic control in patients with type 1 diabetes mellitus on continuous subcutaneous insulin infusion or on multiple daily injections
por: Murata, Takashi, et al.
Publicado: (2015)

Management of glycemic variation in diabetic patients receiving parenteral nutrition by continuous subcutaneous insulin infusion (CSII) therapy
por: Li, Feng-fei, et al.
Publicado: (2018)

Diurnal variation of carbohydrate insulin ratio in adult type 1 diabetic patients treated with continuous subcutaneous insulin infusion
por: Nakamura, Tomoaki, et al.
Publicado: (2014)

Polymorphic Basal Rates of Continuous Subcutaneous Insulin Infusion among Taiwanese Children with Type 1 Diabetes
por: Lin, Chia-Hung, et al.
Publicado: (2015)

Lost in Translation: A Disconnect Between the Science and Medicare Coverage Criteria for Continuous Subcutaneous Insulin Infusion
por: Aleppo, Grazia, et al.
Publicado: (2021)

Continuous Subcutaneous Insulin Infusion Therapy Resulting in Improved Glycemic Control in Patient With Low Health Literacy
por: Mandal, Shobha, et al.
Publicado: (2021)

Evaluation of an Algorithm to Guide Patients With Type 1 Diabetes Treated With Continuous Subcutaneous Insulin Infusion on How to Respond to Real-Time Continuous Glucose Levels: A randomized controlled trial
por: Jenkins, Alicia J., et al.
Publicado: (2010)

Continuous Insulin Infusion: When, Where, and How?
por: Kelly, Janet L.
Publicado: (2014)

Treatment of Severe Hypertriglyceridemia with Continuous Insulin Infusion
por: Rodríguez Santana, Yesica, et al.
Publicado: (2011)

Continuous Glucose Monitoring Enables the Detection of Losses in Infusion Set Actuation (LISAs)
por: Howsmon, Daniel P., et al.
Publicado: (2017)

Glucose Management during Insulinoma Resection Using Real-Time Subcutaneous Continuous Glucose Monitoring
por: Sugiyama, Yuki, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_h5u4icvs30d6kapakks6j55ulm